98 results on '"Fukunaga, Kohji"'
Search Results
2. GPR124 induces NLRP3 inflammasome-mediated pyroptosis in endothelial cells during ischemic injury
3. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice
4. Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
5. Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
6. T-type Ca2+ channel enhancer SAK3 administration improves the BPSD-like behaviors in AppNL−G-F/NL−G-F knock-in mice
7. Gut-brain axis: A matter of concern in neuropsychiatric disorders…!
8. Endothelial peroxynitrite causes disturbance of neuronal oscillations by targeting caspase-1 in the arcuate nucleus
9. Autism spectrum disorder (ASD): Disturbance of the melatonin system and its implications
10. Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands
11. Corrigendum to “Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency” [Neurobiology of Disease 149 (2021) 105224]
12. Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway
13. Combined citicoline and docosahexaenoic acid treatment improves cognitive dysfunction following transient brain ischemia
14. Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels
15. T-type calcium channel enhancer SAK3 produces anti-depressant-like effects by promoting adult hippocampal neurogenesis in olfactory bulbectomized mice
16. The T-type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation
17. Novel spiroimidazopyridine derivative SAK3 improves methimazole-induced cognitive deficits in mice
18. Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction
19. The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis
20. Sigma-1 receptor is involved in modification of ER-mitochondria proximity and Ca2+ homeostasis in cardiomyocytes
21. Atg5 deficit exaggerates the lysosome formation and cathepsin B activation in mice brain after lipid nanoparticles injection
22. Fluvoxamine rescues mitochondrial Ca2 + transport and ATP production through σ1-receptor in hypertrophic cardiomyocytes
23. Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles
24. The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain
25. Interaction of PICK1 with C-Terminus of Growth Hormone–Releasing Hormone Receptor (GHRHR) Modulates Trafficking and Signal Transduction of Human GHRHR
26. The Novel Cognitive Enhancer ST101 Enhances Acetylcholine Release in Mouse Dorsal Hippocampus Through T-type Voltage-Gated Calcium Channel Stimulation
27. Crucial Interactions Between Selective Serotonin Uptake Inhibitors and Sigma-1 Receptor in Heart Failure
28. Expression profiling of Ca2+/calmodulin-dependent signaling molecules in the rat dorsal and ventral hippocampus after acute lead exposure
29. Heparin-binding EGF-like growth factor is required for synaptic plasticity and memory formation
30. Quantitative Measurement of in Vivo Phosphorylation States of Cdk5 Activator p35 by Phos-tag SDS-PAGE
31. Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Proteins Interacting With the Third Cytoplasmic Loop of Dopamine D2 and D3 Receptors
32. β-Amyloid Accumulation in Neurovascular Units Following Brain Embolism
33. Cardioprotection by Vanadium Compounds Targeting Akt-Mediated Signaling
34. Nobiletin, a citrus flavonoid with neurotrophic action, augments protein kinase A-mediated phosphorylation of the AMPA receptor subunit, GluR1, and the postsynaptic receptor response to glutamate in murine hippocampus
35. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression
36. Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo
37. Transcriptional Regulation of Neuronal Genes and Its Effect on Neural Functions: Expression and Function of Forkhead Transcription Factors in Neurons
38. Cytoprotective Effect of 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl] ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e) Against Ischemia/Reperfusion-Induced Injury in Rat Heart Involves Inhibition of Fodrin Breakdown and Protein Tyrosine Nitration
39. Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: Role of Calcium/Calmodulin-Dependent Protein Kinases in Ischemic Neuronal Death
40. The Post-ischemic Administration of 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e), a Novel Calmodulin Antagonist, Prevents Delayed Neuronal Death in Gerbil Hippocampus
41. Akt Is a Molecular Target for Signal Transduction Therapy in Brain Ischemic Insult
42. Amyloid β protein activates PKC-δ and induces translocation of myristoylated alanine-rich C kinase substrate (MARCKS) in microglia
43. DECREASE IN AMYLOID PLAQUE FORMATION BY DISEASE-MODIFYING DRUG SAK3 IN APP KNOCK-IN MICE
44. Acyl-CoA binding domain containing 3 (ACBD3) recruits the protein phosphatase PPM1L to ER–Golgi membrane contact sites
45. SAK3, AN T-TYPE CA2+ CHANNEL STIMULATOR INHIBITS AMYLOID BETA ACCUMULATION
46. NOVEL ALZHEIMER’S THERAPEUTICS CANDIDATE SAK3 ENHANCES THE ACH RELEASE AND LTP INDUCTION IN THE HIPPOCAMPUS
47. O–44 - Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in GH3 cells
48. S19–5 - Calcineurin and Brain Ischemia
49. Disturbance of cerebellar synaptic maturation in mutant mice lacking BSRPs, a novel brain-specific receptor-like protein family
50. Novel Alzheimer's therapeutics: ST101 enhances acetylcholine release through T-type voltage-gated calcium channel
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.